Abstract
Selective Reprogramming of Cd19-Specific T Cells With IL-21 and CD28 Signaling for Adoptive Immunotherapy of Acute Lymphoblastic Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have